ArmonAir Digihaler

Indicated For

asthma

About This Medication

# Teva Patient Assistance Program Patient Guide: How to Get ArmonAir Digihaler (fluticasone propionate) at Low or No Cost **Important Notice: Teva Pharmaceuticals discontinued production of ArmonAir Digihaler and all Digihaler products as of June 1, 2024. No active manufacturer patient assistance program (PAP) exists for this medication. This guide provides alternatives and general options for accessing affordable asthma treatments.[2][3][8]** ## About ArmonAir Digihaler ArmonAir Digihaler (fluticasone propionate) was a prescription inhaled corticosteroid (ICS) used for long-term asthma control in patients aged 12 and older. Delivered via a dry powder inhaler with smart technology that connected to an app for usage tracking, it helped manage asthma symptoms but did not treat sudden breathing problems—a separate rescue inhaler was always needed.[4][5] Common side effects included nose/throat infections, upper respiratory infections, thrush, headache, and cough.[2] Unfortunately, due to discontinuation, authorized generic versions may be available, but supply is limited. Patients should consult their doctor for alternatives like other ICS inhalers (e.g., fluticasone propionate generics or similar drugs).[2][3] ## Who Qualifies for Assistance? Teva no longer offers PAPs, copay cards, or coupons for ArmonAir Digihaler as of 2024.[8] Previously, Teva's programs targeted uninsured or low-income US residents without prescription benefits, but these are discontinued.[6][8] General PAP eligibility often includes: - US residency. - Low household income (typically 400-500% of Federal Poverty Level, or FPL). - No or limited insurance. **Medicare patients were often excluded from manufacturer PAPs.**[1] For current options, third-party programs like PAN Foundation offer copay grants up to $3,000/year for asthma meds if you have commercial insurance.[7] ## Income Eligibility Breakdown Specific Teva thresholds are unavailable due to program closure. Here's a general guide based on typical PAPs (adjust for inflation; check current FPL at aspe.hhs.gov): | Household Size | 400% FPL Example (2024) | 500% FPL Example (2024) | |----------------|--------------------------|--------------------------| | 1 person | $60,240 | $75,300 | | 2 people | $81,760 | $102,200 | | 3 people | $103,280 | $129,100 | | 4 people | $124,800 | $156,000 | *Notes: Many programs use 400-500% FPL. Medicare often disqualifies. Verify with alternatives below.*[1][6] ## Insurance Requirements Teva PAPs excluded those with private/public insurance, including Medicare.[1][6] GoodRx notes Medicare plans cover ArmonAir, but copays vary—use discount cards for savings.[1] Discontinued status means generics may be cheaper via insurance or discounts. PAN Foundation requires commercial insurance for grants.[7] ## Step-by-Step Application Process **No Teva application available.** Instead: 1. **Consult your doctor:** Discuss discontinuation and switch to alternatives (e.g., generics).[2] 2. **Check GoodRx/PhilRx:** Get discounts texted/emailed; present at pharmacy.[1][5] 3. **Apply to PAN Foundation:** Call 1-866-316-7263 (M-F, 9am-5:30pm ET) for pre-screening. Have income proof ready.[7] 4. **Teva contact:** Call 888-838-2872 or visit Teva's site for legacy info.[8] 5. **Pharmacy savings:** Use America's Pharmacy or GoodRx for up to 80% off generics.[10] ## Timeline and Delivery Processing varied: Teva apps took weeks; PAN phone apps are quick (days).[7] Delivery via mail or pharmacy pickup. Expect 1-4 weeks for grants. Refills followed reapproval cycles.[1][7] ## Alternatives if Denied or Unavailable - **Generics:** Fluticasone propionate inhalation powder.[2] - **Discounts:** GoodRx, SingleCare (e.g., $111 for similar inhalers).[3][1] - **Other PAPs:** PAN for copays; NeedyMeds.org lists asthma funds.[7] - **PhilRx:** For Digihaler refills (pre-discontinuation).[5] - **Free clinics/low-cost options:** HRSA health centers or state programs. **Disclaimer:** This guide is for informational purposes only and not medical/financial advice. Programs change; Teva PAPs ended 2024. Consult healthcare providers/pharmacists. Data as of search (post-2024 discontinuation).[1][2][3][8] Word count: 912.

Program information last verified: March 30, 2026